DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ridker PM. et al.
Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
Am Heart J 2011;
162: 597-605.
We do not assume any responsibility for the contents of the web pages of other providers.